STALICLA signs Cooperative Research and Development Agreement (CRADA) with US National Institute on Drug Abuse (NIDA) to cover Phase 3 development of mavoglurant in cocaine use disorder 8-03-2023, 18:00

HERE and Genesys Partner to Tackle Distracted Driving and Deliver Next-Generation Navigation Experiences in India 9-07-2025, 10:30

2ONE Labs Receives Second FDA PMTA 'Acceptance' Notification for Additionally Submitted 2ONE® Branded Nicotine Pouch Products 4-12-2024, 04:44